Ayala Pharmaceuticals

Targeted Therapies for People with Rare Cancers

Active Acquired Startup Acquired Rehovot Founded 2017-01

Website ↗ LinkedIn

Ayala Pharmaceuticals is a clinical-stage precision oncology company dedicated to developing and commercializing potential small molecule therapeutics for patients suffering from rare and aggressive cancers, especially in genetically defined patient populations. Ayalas product candidates, AL101 and AL102, are designed to target cancer by addressing the unde…